cAMP/PKA Signaling Inhibits Osteogenic Differentiation and Bone Formation in Rodent Models
- 1 August 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in Tissue Engineering, Part A
- Vol. 15 (8), 2135-2143
- https://doi.org/10.1089/ten.tea.2008.0512
Abstract
We previously demonstrated that cAMP-mediated protein kinase A (PKA) activation induces in vitro osteogenesis and in vivo bone formation by human mesenchymal stem cells (hMSCs). To analyze the species-specific response of this phenomenon and to translate our findings into a clinical trial, suitable animal models and cell lines are desirable. In this report, we assessed whether PKA plays a similar proosteogenic role played by two commonly used PKA activators—N6,2′-O-dibutyryl-cAMP (db-cAMP) and 8-bromo cAMP (8b-cAMP)—in a number of model systems. To this end, we treated MC3T3-E1 cells, mouse calvarial osteoblasts, mouse MSCs, and rat MSCs with cAMP. We demonstrate that cAMP inhibits osteogenesis in rodent cell types, evidenced by inhibition of osteogenic markers such as alkaline phosphatase (ALP), osteocalcin (BGLAP), and collagen type 1 (COL1A1). In support of this, ex vivo–cultured mouse calvaria exposed to db-cAMP showed a reduction in bone volume. Interestingly, cAMP even stimulated adipogenic differentiation in rat MSCs. Taken together, our data demonstrate that cAMP inhibits osteogenesis in vitro and bone formation ex vivo in rodent models in contrast to our earlier findings in hMSCs. The species discrepancy in response to various osteogenic signals is a critical need to be tested in clinically relevant models to translate the fundamental findings in lower species level to clinical applications.Keywords
This publication has 56 references indexed in Scilit:
- cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- cAMP/PKA Regulates Osteogenesis, Adipogenesis and Ratio of RANKL/OPG mRNA Expression in Mesenchymal Stem Cells by Suppressing LeptinPLOS ONE, 2008
- Osteoblast expression of an engineered G s -coupled receptor dramatically increases bone massProceedings of the National Academy of Sciences of the United States of America, 2008
- A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Cell-Based Bone Tissue EngineeringPLoS Medicine, 2007
- Fibrous Dysplasia as a Stem Cell DiseaseJournal of Bone and Mineral Research, 2006
- Glucocorticoids suppress bone formation via the osteoclastJCI Insight, 2006
- Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathwayExperimental Cell Research, 2004
- Developmental regulation of the growth plateNature, 2003
- The activation of cAMP-dependent protein kinase is directly linked to the inhibition of osteoblast proliferation (UMR-106) by parathyroid hormone-related proteinBiochemical and Biophysical Research Communications, 1991